The FDA announced on 2018-11-02 that Sandoz Inc voluntarily recalled Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg due to cross-contamination with other products. The recall affects specific lots distributed nationwide in 100-capsule and 1000-capsule bottles.
How to tell if you have it
- Brand: Sandoz
- Product: Nitrofurantoin Capsules, USP (Monohydrate/Macrocrystals) 100 mg
- NDC 0185-0122-01 (100-capsule bottles)
- NDC 0185-0122-10 (1000-capsule bottles)
- Lots: JB4952, JA7322, JA7324
- Expiration dates: 03/2020
- Distribution: Nationwide within the United States
- Units affected: 14366 bottles
The hazard
The recall was initiated because of cross-contamination with other products. The FDA classified this as a Class III recall, indicating it is not likely to cause adverse health reactions but violates labeling or manufacturing standards.
Context
GovInfoNow's records show Sandoz Inc has 29 other recalls on record since 2013-10-09. Recent Sandoz recalls include Focalin XR 5mg Capsules (2026-06-01), Cyclophosphamide Injection (2025-09-05), and Ciprofloxacin Otic Suspension (2025-08-13). Other recent recalls of similar products include Appco Pharma Prazosin Capsules Recall (2026-03-27), Glenmark Nebivolol Tablets Recall (2025-11-18), and Asclemed Duloxetine Capsules Recall (2026-05-14).